NOVOGEN LIMITED
NRT - 2007 Annual General Meeting - Mr Christopher Naughton, MD
Sat, 27 Oct 2007 01:15PM
Click to listen to audio on your default player or
Download the latest version of the Flash Player
Mr Chris Naughton
Sat, 27 Oct 2007
01:15PM Australia/NSW
Boardroom Radio Tools
Select a tab above to display more information
NOVOGEN LIMITED (NRT)
ASX code: NRT
Website: http://www.novogen.com
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Pharmaceutical research and development and manufacturing and marketing of health supplements.
Address:
140 Wicks Road
NORTH RYDE
NSW
Phone: (02) 9878 0088
Fax: (02) 9878 0055
Executives & Directors
Mr Philip A Johnston , Chairman, Non Exec. Director
Mr Christopher Naughton , Executive Director, Managing Director, CEO
Prof. Alan James Husband , Executive Director
Mr Peter B Simpson , Non Exec. Director
Prof. Paul J Nestel, AO , Non Exec. Director
Mr Geoffrey M Leppinus , Non Exec. Director
Mr David R Seaton , CFO
Mr Ronald L Erratt , Company Secretary
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Please refer to the relevant stock exchange if any of the above information is incorrect
NOVOGEN LIMITED (NRT) Events
NOVOGEN LIMITED (NRT)
| NV-128 potential activity against cancer stem cells | Tue, 2 Dec 2008 |
| IND filed for triphendiol | Tue, 2 Dec 2008 |
| Appendix 3Y | Tue, 2 Dec 2008 |
| IDMC recommends Marshall Edwards`s OVATURE Trial Continues | Thu, 13 Nov 2008 |
| Appendix 3B | Wed, 5 Nov 2008 |
| Results of Meeting | Mon, 3 Nov 2008 |
| Chairmans Report AGM 2008 | Fri, 31 Oct 2008 |
| Phenoxodiol and NV-128 show potent synergiatic effect | Wed, 29 Oct 2008 |
| Glycotex reports first patient in new study | Wed, 22 Oct 2008 |
| Glycotex Inc announces collaboration | Tue, 21 Oct 2008 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.

























